Select Medical (NYSE:SEM) Posts Earnings Results, Misses Expectations By $0.11 EPS

Select Medical (NYSE:SEM) announced its quarterly earnings results on Thursday. The health services provider reported $0.18 EPS for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.11), Zacks reports. The company had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.50 billion. Select Medical had a return on equity of 14.04% and a net margin of 3.23%. Select Medical updated its FY 2025 guidance to 1.090-1.190 EPS.

Select Medical Price Performance

Shares of NYSE:SEM opened at $17.63 on Friday. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. Select Medical has a 1-year low of $16.20 and a 1-year high of $40.98. The company has a market capitalization of $2.28 billion, a P/E ratio of 10.68, a P/E/G ratio of 0.64 and a beta of 1.45. The firm’s 50 day simple moving average is $19.13 and its two-hundred day simple moving average is $28.07.

Select Medical Cuts Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, March 13th. Shareholders of record on Monday, March 3rd will be issued a dividend of $0.0625 per share. This represents a $0.25 annualized dividend and a yield of 1.42%. The ex-dividend date is Monday, March 3rd. Select Medical’s dividend payout ratio is currently 30.30%.

Analyst Upgrades and Downgrades

SEM has been the topic of a number of research reports. StockNews.com raised shares of Select Medical from a “hold” rating to a “buy” rating in a report on Friday. Benchmark downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th. UBS Group dropped their price objective on shares of Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a report on Friday, January 3rd. Finally, Royal Bank of Canada raised their price objective on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $39.50.

Insider Buying and Selling at Select Medical

In other news, VP Robert G. Breighner, Jr. sold 4,989 shares of Select Medical stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total transaction of $99,530.55. Following the sale, the vice president now owns 30,356 shares in the company, valued at $605,602.20. This trade represents a 14.12 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Marilyn B. Tavenner sold 32,000 shares of Select Medical stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total transaction of $674,880.00. Following the sale, the director now owns 22,000 shares in the company, valued at approximately $463,980. The trade was a 59.26 % decrease in their position. The disclosure for this sale can be found here. Insiders own 19.14% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.